Bayer AG

OTC: BAYRY · Real-Time Price · USD
7.54
0.01 (0.13%)
At close: Jun 06, 2025, 3:59 PM

Bayer Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
46.61B 47.64B 50.74B 44.08B
Cost of Revenue
21.27B 19.75B 19.87B 16.82B
Gross Profit
25.34B 27.89B 30.87B 27.27B
Operating Income
3.33B -150M 6.26B 6.97B
Interest Income
521M 429M 379M 346M
Pretax Income
-2.33B -1.62B 4.67B 2.05B
Net Income
-2.55B -2.94B 4.15B 1B
Selling & General & Admin
15.94B 14.94B 16.92B 15.32B
Research & Development
6.21B 5.37B 6.57B 5.41B
Other Expenses
-138M 7.58B 41M -381M
Operating Expenses
22.01B 27.89B 23.54B 20.36B
Interest Expense
2.36B 2.05B 1.86B 1.35B
Selling & Marketing Expenses
13.36B 12.48B 14.08B 12.36B
Cost & Expenses
43.28B 47.64B 43.41B 37.17B
Income Tax Expense
212M 1.32B 504M 1.02B
Shares Outstanding (Basic)
3.93B 3.93B 3.93B 3.93B
Shares Outstanding (Diluted)
3.93B 3.93B 3.93B 3.93B
EPS (Basic)
-0.65 -0.75 1.06 0.26
EPS (Diluted)
-0.65 -0.75 1.06 0.26
EBITDA
8.81B 4.21B 10.44B 6.97B
EBIT
24M 426M 6.53B 3.23B
Depreciation & Amortization
8.78B 10.02B 3.95B 3.74B